We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
Cap. Flow
-$301M
Cap. Flow %
-3.99%
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$25.4M
2
ABBV icon
AbbVie
ABBV
+$21.9M
3
KYNB
Kyntra Bio
KYNB
+$19.2M
4
WM icon
Waste Management
WM
+$19M
5
GILD icon
Gilead Sciences
GILD
+$17.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$70.2M
2
ARRY
Array Biopharma Inc
ARRY
+$45.8M
3
BIIB icon
Biogen
BIIB
+$43.3M
4
META icon
Meta Platforms (Facebook)
META
+$24.8M
5
AMGN icon
Amgen
AMGN
+$21.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 18.27%
3 Financials 10.05%
4 Consumer Discretionary 9.39%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HPQ icon
376
HP
HPQ
$24.3B
$3.56M 0.05%
187,920
+9,722
+5% +$191K
CY
377
DELISTED
Cypress Semiconductor
CY
$3.55M 0.05%
+152,069
New +$3.48M
HUM icon
378
Humana
HUM
$45.8B
$3.53M 0.05%
13,818
-7,773
-36% -$2.18M
IP icon
379
International Paper
IP
$22.5B
$3.52M 0.05%
88,907
+10,332
+13% +$404K
TAP icon
380
Molson Coors Class B
TAP
$7.71B
$3.52M 0.05%
61,165
+15,787
+35% +$856K
PVH icon
381
PVH
PVH
$3.87B
$3.48M 0.05%
39,490
-21,079
-35% -$1.76M
CHRS icon
382
Coherus Oncology
CHRS
$225M
$3.48M 0.05%
171,919
+106,919
+164% +$2.14M
ACHN
383
DELISTED
Achillion Pharmaceuticals
ACHN
$3.47M 0.05%
965,000
+240,000
+33% +$925K
RVTY icon
384
Revvity
RVTY
$12.1B
$3.41M 0.05%
40,000
– –
BFH icon
385
Bread Financial
BFH
$4.29B
$3.4M 0.05%
33,213
-14,891
-31% -$1.68M
AVB icon
386
AvalonBay Communities
AVB
$26.8B
$3.35M 0.04%
15,534
+851
+6% +$178K
YUMC icon
387
Yum China
YUMC
$15.3B
$3.32M 0.04%
73,170
– –
YUM icon
388
Yum! Brands
YUM
$40.7B
$3.3M 0.04%
29,085
+2,707
+10% +$309K
HPE icon
389
Hewlett Packard
HPE
$63.8B
$3.27M 0.04%
215,712
-30,589
-12% -$435K
BALL icon
390
Ball Corp
BALL
$17.2B
$3.24M 0.04%
44,477
+12,674
+40% +$944K
CNC icon
391
Centene
CNC
$31.6B
– –
-27,879
Closed -$1.36M
OMN
392
DELISTED
OMNOVA Solutions Inc.
OMN
$3.22M 0.04%
+319,451
New +$3.17M
KEY icon
393
KeyCorp
KEY
$24.1B
$3.2M 0.04%
179,335
-76,558
-30% -$1.32M
TU icon
394
Telus
TU
$16.2B
$3.19M 0.04%
179,466
-24,802
-12% -$451K
MCO icon
395
Moody's
MCO
$84.2B
$3.18M 0.04%
15,541
-671
-4% -$141K
MYOK
396
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$3.18M 0.04%
61,000
– –
PLNT icon
397
Planet Fitness
PLNT
$4.29B
$3.18M 0.04%
54,909
+1,718
+3% +$121K
TER icon
398
Teradyne
TER
$52.4B
$3.09M 0.04%
+53,291
New +$2.82M
RVNC
399
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.08M 0.04%
237,000
– –
BNS icon
400
Scotiabank
BNS
$106B
$3.05M 0.04%
53,602
-9,142
-15% -$491K
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2019 Portfolio in Review

As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.

  • Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
  • Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
  • Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
  • Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
  • Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
  • Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
  • Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.